Research and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation team at MFT.
Heart attack patients could be treated more quickly after Manchester research
Clinical judgement, combined with an electrocardiogram (ECG) and blood test on arrival, is effective in reducing unnecessary hospital admissions for chest pain, a new study shows.
BRU attends Association of Medical Research Charities parliamentary event
Leading figures of the charity, public and private medical research community gathered in Parliament to showcase ground-breaking research and the health, social and economic benefits it has brought.
Watch Dr Sebastien Viatte discuss his research at the EULAR Congress
Dr Sebastien Viatte spoke at the European League Against Rheumatism Congress 2014 press conference about his latest research into genotyping and arthritis.
£50,000 awarded to help young people have their say
Involvement from patients in priority setting around rheumatology research is vital. However, to date little work has been done to understand younger patients’ views.
Manchester Centre in Biological Timing in Disease
It is well known that circadian clock dysfunction contributes to the incidence and severity of many diseases, including inflammation and metabolic syndrome.
Royal Manchester Children’s Hospital patient first-in-the-world to take part in Hunter Syndrome trial
Four year old Joe Hiller, who has a rare inherited disease, has become the first person in the world to participate in a new trial which could alter the lives of fellow sufferers.
Manchester research featured in BBC Day of the Body Clock
David Ray, Professor of Medicine and Endocrinology and Consultant at Manchester Royal Infirmary, was one of a number of researchers feature in a BBC special about the circadian rhythm.
Manchester research key to development of the first ever treatment for rare genetic condition
The first and only treatment designed for children and adults with the rare genetic condition, Morquio A syndrome, has now been approved for use in the European Union.